institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published Updated

Physicians Committee Complaint Calls on OHSU to Suspend Decades-Long Alcohol Experiments on Nonhuman Primates

Summary by Physicians Committee for Responsible Medicine
Physicians Committee Complaint Calls on OHSU to Suspend Decades-Long Alcohol Experiments on Nonhuman Primates Michael Keevican Mon, 05/19/2025 - 08:35 Featured Image Rhesus-Macaque-monkey.jpg Summary The Physicians Committee for Responsible Medicine, a nonprofit medical ethics group, is filing a complaint on Monday, May 19, calling on Oregon Health & Science University to suspend decades-long alcohol-related experiments on nonhuman primates th…

3 Articles

All
Left
Center
Right
1
Right

A team led by biologist Jürgen Knoblich has been awarded the State Prize for the promotion of replacement methods for animal experiments. Researchers at the Institute of Molecular Biotechnology (IMBA) in Vienna are breeding brain tissue in the laboratory to investigate diseases. Since brain diseases often fail late in development, thousands of animal experiments are carried out for free, said molecular biologist Jürgen Knoblich. The technology o…

·Vienna, Austria
Read Full Article

IMBA researchers developed brain organoids to investigate disorders in the connection of the brain halves.

·Salzburg, Austria
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Physicians Committee for Responsible Medicine broke the news in on Monday, May 19, 2025.
Sources are mostly out of Austria (2)

You have read 2 out of your 5 free daily articles.

Our use of cookies
Unlike other news sites, we do not share or sell your data to third-parties for targeted ads.
By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.